ACADIA Pharmaceuticals, Inc. (ACAD)
25.99
-0.54
(-2.04%)
USD |
NASDAQ |
Jan 16, 16:00
25.98
-0.01
(-0.04%)
Pre-Market: 20:00
ACADIA Pharmaceuticals EPS Diluted (Quarterly): 0.4206 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amicus Therapeutics, Inc. | 0.0558 |
| ANI Pharmaceuticals, Inc. | 1.133 |
| Catalyst Pharmaceuticals, Inc. | 0.4153 |
| Regeneron Pharmaceuticals, Inc. | 13.62 |
| Puma Biotechnology, Inc. | 0.1736 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 71.78M |
| Revenue (Quarterly) | 278.63M |
| Total Expenses (Quarterly) | 206.85M |
| Enterprise Value | 3.605B |
| Gross Profit Margin (Quarterly) | 92.23% |
| Profit Margin (Quarterly) | 25.76% |
| Earnings Yield | 5.98% |
| Operating Earnings Yield | 2.16% |
| Normalized Earnings Yield | 5.98 |